Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology

Background: Four previously reported studies have tested for association of blood proteins with neocortical amyloid-β burden (NAB). If shown to be robust, these proteins could have utility as a blood test for enrichment in clinical trials of Alzheimer’s disease (AD) therapeutics. Objective: This stu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Alzheimers Dis
Glavni autori: Voyle, Nicola, Baker, David, Burnham, Samantha C., Covin, Antonia, Zhang, Zhanpan, Sangurdekar, Dipen P., Tan Hehir, Cristina A., Bazenet, Chantal, Lovestone, Simon, Kiddle, Steven, Dobson, Richard J.B.
Format: Artigo
Jezik:Inglês
Izdano: IOS Press 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4923714/
https://ncbi.nlm.nih.gov/pubmed/25881911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-150020
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items